Accelerate Diagnostics Inc (AXDX):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Accelerate Diagnostics Inc (AXDX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7098
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Accelerate Diagnostics Inc (Accelerate) is an in vitro diagnostics company that undertakes the development and commercialization of instrumentation for identification and testing the antibiotic susceptibility of infectious pathogens. Its product portfolio includes Accelerate Pheno system, in vitro diagnostic platform for the identification (ID) and antibiotic susceptibility testing (AST) of infectious pathogens; and Accelerate PhenoTest BC kit which provides ID and AST results for patients suspected of bacteremia or fungemia. Accelerate uses its proprietary molecular identification methods and morphokinetic cellular analysis to provide faster quantitative ID/AST results. The company has a manufacturing facility in Tucson, Arizona. Accelerate is headquartered in Tucson, Arizona, the US.

Accelerate Diagnostics Inc (AXDX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Accelerate Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Accelerate Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Accelerate Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Accelerate Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Accelerate Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Accelerate Diagnostics Inc, Medical Equipment, Deal Details 10
Partnerships 10
Accelerate Diagnostics Enters into Co-Development Agreement with Centers for Disease Control and Prevention 10
Equity Offering 11
Accelerate Diagnostics Raises USD79.3 Million in Public Offering of Shares 11
Accelerate Diagnostics Raises USD109.3 Million in Public Offering of Shares 13
Accelerate Diagnostics Completes Rights Offering Of Shares For US$45 Million 15
Accelerate Diagnostics Files Registration Statement For Public Offering Of Securities For Up To US$150 Million 16
Accelerate Diagnostics Completes Rights Offering Of Shares For US$20 Million 17
Accelr8 Technology Completes Private Placement Of Shares For US$14.4 Million 18
Debt Offering 19
Accelerate Diagnostics Prices Private Placement of 2.5% Notes Due 2023 for USD150 Million 19
Accelerate Diagnostics Inc – Key Competitors 20
Accelerate Diagnostics Inc – Key Employees 21
Accelerate Diagnostics Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Aug 06, 2018: Accelerate Diagnostics reports Q2 2018 financial results 23
May 09, 2018: Accelerate Diagnostics reports Q1 2018 financial results 24
Feb 15, 2018: Accelerate Diagnostics reports Q4 and Full-Year Financial Results for 2017 25
Nov 02, 2017: Accelerate Diagnostics reports Q3 2017 financial results 26
Aug 03, 2017: Accelerate Diagnostics Reports Q2 2017 Financial Results, Doubles Revenue Generating Placements 27
May 03, 2017: Accelerate Diagnostics Reports 191 Instruments Under Contract and 3x Revenue Growth for First Quarter 2017 28
Corporate Communications 29
Sep 27, 2018: Accelerate Diagnostics announces resignation of Joan Martin as Head of Europe, Middle East, and Africa 29
Nov 16, 2017: Accelerate Diagnostics Welcomes Dr. Charles Watts to its Board of Directors 30
Jul 31, 2017: Accelerate Diagnostics Welcomes Dr. Romney Humphries as Chief Scientific Officer 31
Mar 15, 2017: Accelerate Diagnostics Names Tom Brown to Board of Directors 32
Product News 33
May 30, 2017: Accelerate Diagnostics announces sizeable release of data at ASM Microbe 2017 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Accelerate Diagnostics Inc, Medical Equipment, Key Facts, 2017 2
Accelerate Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Accelerate Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Accelerate Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Accelerate Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Accelerate Diagnostics Inc, Deals By Market, 2012 to YTD 2018 8
Accelerate Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Accelerate Diagnostics Enters into Co-Development Agreement with Centers for Disease Control and Prevention 10
Accelerate Diagnostics Raises USD79.3 Million in Public Offering of Shares 11
Accelerate Diagnostics Raises USD109.3 Million in Public Offering of Shares 13
Accelerate Diagnostics Completes Rights Offering Of Shares For US$45 Million 15
Accelerate Diagnostics Files Registration Statement For Public Offering Of Securities For Up To US$150 Million 16
Accelerate Diagnostics Completes Rights Offering Of Shares For US$20 Million 17
Accelr8 Technology Completes Private Placement Of Shares For US$14.4 Million 18
Accelerate Diagnostics Prices Private Placement of 2.5% Notes Due 2023 for USD150 Million 19
Accelerate Diagnostics Inc, Key Competitors 20
Accelerate Diagnostics Inc, Key Employees 21
Accelerate Diagnostics Inc, Subsidiaries 22

List of Figures
Accelerate Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Accelerate Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Accelerate Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Accelerate Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Accelerate Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Accelerate Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Accelerate Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Accelerate Diagnostics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Accelerate Diagnostics Inc (AXDX):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Moberg Pharma AB (MOB):製薬・医療:M&Aディール及び事業提携情報
    Summary Moberg Pharma AB (Moberg Pharma), formerly Moberg Derma AB, is a pharmaceutical company. The company provides commercializes proprietary, acquired and licensed products. It provides treatment of skin diseases. Moberg Pharma treats fungal infection or psoriasis, discolored and fungus-damaged …
  • Bio-Reference Laboratories Inc:企業の戦略的SWOT分析
    Bio-Reference Laboratories Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Trelleborg AB:企業の戦略・SWOT・財務情報
    Trelleborg AB - Strategy, SWOT and Corporate Finance Report Summary Trelleborg AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Loblaw Companies Ltd (L):企業の財務・戦略的SWOT分析
    Loblaw Companies Ltd (L) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Verisante Technology Inc (VRS)-医療機器分野:企業M&A・提携分析
    Summary Verisante Technology Inc (Verisante), develops and commercializes products for the early detection of all forms of skin cancer. The company’s key product offerings include Verisante Aura, Verisante Core and Verisante MSI Camera. The Verisante Aura is used for skin cancer detection, and Veris …
  • AGA Rangemaster Group Ltd:企業の戦略的SWOT分析
    AGA Rangemaster Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Grupa Azoty Zaklady Chemiczne Police SA (PCE):企業の財務・戦略的SWOT分析
    Grupa Azoty Zaklady Chemiczne Police SA (PCE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Texas Instruments Incorporated (TXN):電力:M&Aディール及び事業提携情報
    Summary Texas Instruments Incorporated (TI) designs and manufactures and sells semiconductors to electronics designers and manufacturers the world over. It offers catalog and application-specific standard semiconductor products through its analog chips and embedded processors divisions. Its analog c …
  • HDFC Standard Life Insurance Company Limited:企業の戦略・SWOT・財務情報
    HDFC Standard Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary HDFC Standard Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Isrotel Hotels Management Inc.:企業の戦略・SWOT・財務分析
    Isrotel Hotels Management Inc. - Strategy, SWOT and Corporate Finance Report Summary Isrotel Hotels Management Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Genticel SA (GTCL)-製薬・医療分野:企業M&A・提携分析
    Summary Genticel SA (Genticel), formerly BT Pharma, is a biopharmaceutical company that develops therapeutic vaccines for women infected by the human papillomavirus. The company provides pipeline products including ProCervix, a bivalent HPV therapeutic vaccine candidate and multivalent candidate vac …
  • Rna Diagnostics Inc:企業の製品パイプライン分析2018
    Summary Rna Diagnostics Inc (Rna Diagnostics) is a medical device company that discovers and develops medical diagnostics molecular diagnostic technologies. The company offers diagnostic tools used in treatment of women undergoing chemotherapy for breast cancer. It also provides solutions to manage …
  • Guerbet SA (GBT):企業の財務・戦略的SWOT分析
    Guerbet SA (GBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • The Nisshin OilliO Group, Ltd.:企業の戦略・SWOT・財務情報
    The Nisshin OilliO Group, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Nisshin OilliO Group, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Landis+Gyr AG:企業の戦略的SWOT分析
    Landis+Gyr AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • UnitedHealth Group Incorporated:企業の戦略・SWOT・財務情報
    UnitedHealth Group Incorporated - Strategy, SWOT and Corporate Finance Report Summary UnitedHealth Group Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Stada Arzneimittel AG (SAZ):製薬・医療:M&Aディール及び事業提携情報
    Summary Stada Arzneimittel AG (STADA) is a manufacturer of low-cost generics and branded over the counter products. The company develops and markets drugs with off-patent active pharmaceutical ingredients, particularly, which are free from commercial property rights. It offers a portfolio of product …
  • Bayer Healthcare Pharmaceuticals:企業の戦略・SWOT・財務情報
    Bayer Healthcare Pharmaceuticals - Strategy, SWOT and Corporate Finance Report Summary Bayer Healthcare Pharmaceuticals - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Delta NV-エネルギー分野:企業M&A・提携分析
    Summary Delta N.V. (Delta) is an independent multi-utility company. It provides energy, network and infrastructure services, and digital services. The company generates electricity, transmits and trades in energy, and supplies gas and power. Delta provides cable services for both analogue and digita …
  • EOS imaging SA (EOSI):企業の財務・戦略的SWOT分析
    EOS imaging SA (EOSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆